Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy
Authors
Keywords
-
Journal
ANNALS OF NEUROLOGY
Volume 76, Issue 6, Pages 792-801
Publisher
Wiley
Online
2014-04-11
DOI
10.1002/ana.24153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progressive multifocal leukoencephalopathy after natalizumab discontinuation
- (2013) Andrew J. Fine et al. ANNALS OF NEUROLOGY
- Interpretation of positive molecular tests of common viruses in the cerebrospinal fluid
- (2013) Archana Bhaskaran et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants
- (2013) Caroline F. Ryschkewitsch et al. JOURNAL OF CLINICAL VIROLOGY
- Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?
- (2013) Mike P Wattjes et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Changes to anti-JCV antibody levels in a Swedish national MS cohort
- (2013) Clemens Warnke et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients
- (2013) Stefanie Dahlhaus et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- An assay to quantify species-specific anti-JC virus antibody levels in MS patients
- (2013) Clemens Warnke et al. Multiple Sclerosis Journal
- The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy
- (2013) Mike P Wattjes et al. Multiple Sclerosis Journal
- L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
- (2013) N. Schwab et al. NEUROLOGY
- Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis
- (2013) C. Warnke et al. NEUROLOGY
- PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section
- (2013) J. R. Berger et al. NEUROLOGY
- Value of MRI as a surrogate marker for PML in natalizumab long-term therapy
- (2012) I. Ayzenberg et al. JOURNAL OF NEUROLOGY
- Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies
- (2012) Dirk Mentzer et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The effect of plasma exchange on serum anti-JC virus antibodies
- (2012) Meena Subramanyam et al. Multiple Sclerosis Journal
- Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
- (2012) A. K. Trampe et al. NEUROLOGY
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
- (2011) Imke Metz et al. ACTA NEUROPATHOLOGICA
- Natalizumab and Impedance of the Homing of CD34+ Hematopoietic Progenitors
- (2011) Christian Saure ARCHIVES OF NEUROLOGY
- Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome
- (2011) Lilian Aly et al. BRAIN
- Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
- (2011) Ludwig Kappos et al. LANCET NEUROLOGY
- Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS
- (2011) J. Kuhle et al. NEUROLOGY
- Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS
- (2011) A. Vennegoor et al. NEUROLOGY
- JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab
- (2010) Caroline F. Ryschkewitsch et al. ANNALS OF NEUROLOGY
- Assessment of JC virus DNA in blood and urine from natalizumab-treated patients
- (2010) Clemens Warnke et al. ANNALS OF NEUROLOGY
- Natalizumab and Progressive Multifocal Leukoencephalopathy
- (2010) Clemens Warnke et al. ARCHIVES OF NEUROLOGY
- Discrepant findings in immune responses to JC virus in patients receiving natalizumab
- (2010) Chen S Tan et al. LANCET NEUROLOGY
- Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study
- (2010) Samantha Jilek et al. LANCET NEUROLOGY
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus
- (2010) Clemens Warnke et al. Multiple Sclerosis Journal
- Swedish natalizumab (Tysabri) multiple sclerosis surveillance study
- (2010) Fredrik Piehl et al. NEUROLOGICAL SCIENCES
- Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
- (2009) Yiping Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA
- (2008) E Iacobaeus et al. Multiple Sclerosis Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now